-
公开(公告)号:US11578032B2
公开(公告)日:2023-02-14
申请号:US16969793
申请日:2019-02-13
发明人: Thomas Scanlan
IPC分类号: C07C233/40 , C07C233/11 , C07C233/13 , C07C233/22
摘要: Compounds are provided that function as thyromimetics, which compounds have utility for treating diseases such as neurodegenerative disorders. Pharmaceutical compositions containing such compounds are also provided, as are methods of their use and preparation. Such compounds have the structure of Formula (I) as shown herein, or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope or salt thereof.
-
公开(公告)号:US20230028963A1
公开(公告)日:2023-01-26
申请号:US17960636
申请日:2022-10-05
摘要: An anatomical sensing system-guided prostate procedure device that includes a housing having a proximal end and a distal end. The housing may be divided into a distal housing section, amid housing section, and a proximal housing section, wherein the distal housing section is configured for insertion into the anus and retention in the rectum of a subject. The device further includes an instrument convergence point disposed between the proximal end and the distal end, the convergence point configured to allow an instrument pass though the instrument convergence point at a variable angle; and an instrument angle orienting system at the proximal end of the housing, the angle orienting system directing an orientation of the variable angle about the convergence point. Methods of the using an anatomical sensing system-guided prostate procedure device and system including the same.
-
公开(公告)号:US11492359B2
公开(公告)日:2022-11-08
申请号:US17263863
申请日:2019-07-26
发明人: Summer L. Gibbs , Lei G. Wang , Connor W. Barth
IPC分类号: C07D498/22 , C07D498/16 , A61K49/00
摘要: The compounds provided herein are phenoxazines that can be used as far red to near-infrared nerve-sparing fluorescent compounds in medical procedures.
-
公开(公告)号:US20220133753A1
公开(公告)日:2022-05-05
申请号:US17340665
申请日:2021-06-07
申请人: Comet Therapeutics, Inc. , RIJKSUNIVERSITEIT GRONINGEN , ACADEMISCH ZIEKENHUIS GRONINGEN , Oregon Health & Science University
发明人: Gregor KOSEC , Ajda Podgorsek BERKE , Hrvoje PETKOVIC , Oda Cornelia Maria SIBON , Balaji SRINIVASAN , Susan J. HAYFLICK
IPC分类号: A61K31/661 , A61P1/14
摘要: Methods and pharmaceutical compositions for use in treating diseases associated with insufficient activity of the pantothenate kinase enzyme (e.g., CASTOR diseases) are disclosed. The methods and compositions involve an effective amount of an active derivative of 4′-phosphopantetheine.
-
公开(公告)号:US20220133715A1
公开(公告)日:2022-05-05
申请号:US17434278
申请日:2020-02-26
IPC分类号: A61K31/496 , A61K31/635 , A61P35/02 , A61K31/437 , A61K31/4545 , A61K31/5377 , A61K31/506
摘要: The present invention concerns novel methods of treatment for venetoclax-resistant acute myeloid leukemia, particularly in subjects with a low expression of TP53 protein or expression of TP53 protein associated with a mutation of the TP53 gene, the methods comprising administering to the subject in need thereof a therapeutically effective amount of a NTRK/ALK/ROS1 inhibitor, or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US11302043B2
公开(公告)日:2022-04-12
申请号:US16803629
申请日:2020-02-27
发明人: Acner Camino , David Huang , Yali Jia
摘要: Disclosed herein are methods and systems for automated detection of shadow artifacts in optical coherence tomography (OCT) and/or OCT angiography (OCTA). The shadow detection includes applying a machine-learning algorithm to the OCT dataset and the OCTA dataset to detect one or more shadow artifacts in the sample. The machine-learning algorithm is trained with first training data from first training samples that include manufactured shadows and no perfusion defects and second training data from second training samples that include perfusion defects and no manufactured shadows. The shadow artifacts in the OCTA dataset and/or OCT dataset may be suppressed to generate a shadow-suppressed OCTA dataset and/or a shadow-suppressed OCT dataset, respectively. Other embodiments may be described and claimed.
-
公开(公告)号:US20220058839A1
公开(公告)日:2022-02-24
申请号:US17419693
申请日:2019-12-30
发明人: Young Hwan Chang , Erik Burlingame , Geoffrey Schau , Joe W. Gray
摘要: Techniques and systems for translating images of biological samples stained according to a first staining technique into images representing the biological samples stained according to a second staining technique. In various implementations, the first staining technique can include a histopathological staining technique and the second staining technique can include an immunofluorescence staining technique or an immunohistochemistry staining technique.
-
公开(公告)号:US11213461B2
公开(公告)日:2022-01-04
申请号:US16335167
申请日:2017-10-03
摘要: Enteric feeding tube housings configured to secure a feeding tube to the body are disclosed. The housing includes a disc having a hole configured to accommodate the feeding tube and two or more holes configured to accommodate fasteners. Also disclosed are enteric feeding tube housings that include a disc having a hole configured to accommodate the feeding tube and two or more holes configured to accommodate fasteners, and a plurality of fasteners. Also disclosed are surgical kits that include a housing, a plurality of fasteners, and a plurality of locking devices configured to adjustably secure the fasteners in the fastener receiving holes, and method of using the disclosed devices.
-
公开(公告)号:US20210402053A1
公开(公告)日:2021-12-30
申请号:US17279437
申请日:2019-09-25
发明人: Luiz E. Bertassoni
摘要: This disclosure relates to methods of mineralizing cell-laden matrices. Disclosed herein are cell-laden matrix compositions. Also disclosed herein are methods of selectively mineralizing a cell-laden matrix. Methods of culturing biomimetic bone tissue are disclosed herein. Also disclosed herein are kits containing compositions disclosed herein or portions thereof.
-
公开(公告)号:US20210353619A1
公开(公告)日:2021-11-18
申请号:US17290649
申请日:2019-10-30
发明人: Jeffrey W. Tyner , Haijiao Zhang
IPC分类号: A61K31/496 , A61K45/06 , A61K31/519 , A61K31/44 , A61K31/5355 , A61K31/5377 , A61P35/02
摘要: Provided herein are methods and therapeutic combinations useful in the treatment of venetoclax-resistant Acute Myeloid Leukemia and of venetoclax-sensitive Acute Myeloid Leukemia.
-
-
-
-
-
-
-
-
-